TTK Healthcare Approves FY2026 Results, Recommends Rs. 10 Dividend, and Reappoints Chairman
TTK Healthcare Limited announced the approval of its Audited Financial Results for the Fourth Quarter and the entire year ended March 31, 2026. At a Board meeting held on May 30, 2026, the Board took several key resolutions concerning leadership, accounting, and shareholder returns.The Company recommended a dividend of Rs. 10/- per Equity Share (100%) of Rs. 10/- each for the financial year ended March 31, 2026. This dividend is subject to the approval of the shareholders at the ensuing 68th Annual General Meeting (AGM), which is scheduled for Friday, July 24, 2026.
The Board also approved the reappointment of Mr. T T Raghunathan as Executive Chairman (Wholetime Director). This appointment extends his current term for a further period of 5 years, with effect from November 01, 2026.
Furthermore, M/s Geeyes & Co. was appointed as the Cost Auditor of the Company for the financial year 2026-27.
Financial Performance Highlights
The Company released detailed financial statements for the Fourth Quarter and the Year ended March 31, 2026. The audited financial highlights show significant figures across the key performance indicators.The financial results for the years ended March 31, 2026, and March 31, 2025, are detailed below:
| Metric (Rs. in lakhs) | 2025-26 | 2024-25 |
|---|---|---|
| Total Income | 92,943.11 | 87,274.83 |
| Cost of Materials Consumed | 40,348.87 | 36,891.64 |
| Employee Benefits Expense | 16,516.12 | 15,090.96 |
| Other Expenses | 26,245.54 | 24,683.92 |
| Profit before Exceptional Items and Tax | 8,663.75 | 9,442.52 |
| Exceptional Items: Profit on sale of Land / Loss on write-off of Inventories | (407.45) | 1,390.66 |
| Profit before Tax | 8,256.30 | 10,833.18 |
| Profit after Tax | 6,568.05 | 8,165.69 |
Total Income from Operations saw consistent growth, reporting Rs. 85,728.11 lakhs for the year ended March 31, 2026, compared to Rs. 80,149.34 lakhs in the previous year.
The Company's Segment Revenue demonstrated varied performance:
| Segment | Total Revenue (Year Ended 31/03/2026) | Total Revenue (Year Ended 31/03/2025) |
|---|---|---|
| Consumer Products | 24,127.82 lakhs | 24,492.52 lakhs |
| Protective Devices | 21,650.81 lakhs | 20,663.87 lakhs |
| Medical Devices | 10,691.69 lakhs | 9,014.53 lakhs |
| Foods | 15,109.96 lakhs | 13,305.98 lakhs |
Financial Structure and Capitalization
The Company’s total assets stood at Rs. 132,874.25 lakhs as of March 31, 2026, compared to Rs. 128,118.67 lakhs on the same date in the previous year.Regarding equity structure, the total equity increased to Rs. 1,11,45.0t lakhs, reflecting the Company's strong capital base.
Management and Governance Updates
The Board of Directors also approved the appointment of the 68th Annual General Meeting for Friday, July 24, 2026, to be held through Video Conferencing / Other Audio Visual Means.During the meeting, the Board noted that the financial results include:
- An exceptional income of Rs. 350.41 lakhs from GST refund relating to earlier periods.
- Exceptional items from the previous year, including a profit on sale of Leasehold land with building at Mahindra World City, Chennai, amounting to Rs. 1,977.05 lakhs (Net).
- The Board recommends the reappointment of Mr. T T Raghunathan for a term of five years, effective November 01, 2026.
The audited financial statements for the quarter and year ended March 31, 2026, received an unmodified opinion from the Statutory Auditors, M/s PKF Sridhar & Santhanam LLP, Chartered Accountants.
TTKHLTCARE Stock Price Movement
Shares of TTK Healthcare Limited are edging higher to ₹918.7 as of 3:01 PM today, gaining 3.01% in live trading. This upward momentum is currently supported by a healthy trading volume of 7,887 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.
Last edited by a moderator: